Press release
Cmed and Larix fully integrated into Aixial Group, the CRO solution of ALTEN Group
Following its acquisition of Larix in 2019 and Cmed Group in 2021, Aixial Group has become a leading mid-size, global CRO, with strong US and European presence and more than 1,000 employees.With over 30 years' experience in successful project delivery, Aixial Group continues to grow with the full integration of Larix and Cmed enabling it to extend its expertise and offerings, with more options for biotech and pharma sponsors at both the local and global levels. As a specialized clinical development partner, Aixial Group provides the industry with an innovative and scalable offering, which includes: comprehensive clinical trial design and execution; functional service delivery; resources and platform.
Luca Ferro, Aixial Group's Managing Director commented: "This is a very exciting time, as after a successful transition, Cmed, and Larix have now seamlessly integrated into the Aixial Group. We offer a fresh new approach with worldwide expertise, a distinctive and flexible operating model designed to meet the demands of each phase of development, and a global delivery model created to optimize the cost and speed of any project for global biotech and pharma companies. Our reinforced expertise in oncology, cell & gene, and rare disease therapies, combined with our commitment and flexibility, enable us to deliver the most efficient clinical trials possible."
Mr. Ferro continues: "Our mission is to empower sponsors with our expertise and efficient processes, starting from the concept stage onward. We provide support as trusted advisors and value-added experts, delivering quality work and innovation, all with a patient-centric approach. We have a proven history and will continue to employ the best talents in the industry and improve upon our processes, all to ensure sponsors around the world achieve positive outcomes for the patients who seek new treatments for their debilitating disease diagnoses."
Following the integration, the company has now unveiled its new website, brand vision, mission and values to the industry. This combined offering is summed up by its new tagline: 'Bringing reliability and expertise to clinical development'.
For more information and to see the new website, please visit: aixialgroup.com
The Scott Partnership,
1 Whiteside, Station Road, Cheshire, CW4 8AA
Alisha Mountford, ajm@scottpr.com
About Aixial Group
Aixial Group, the CRO solution of ALTEN Group, is a leader in CRO services with expertise in oncology, cell & gene, and rare disease therapies that spans the entire development of pharmaceuticals, biologics, and devices. Aixial Group has more than 1,000 employees worldwide providing a wide range of solutions-related CRO services including clinical operations, data management and biostatistical consulting, pharmacovigilance/drug safety, regulatory affairs, quality assurance, medical writing, and continuously expanding services in real world evidence.
About ALTEN Group
Created in 1988, ALTEN supports its customers' development strategies in the areas of innovation, R&D and technological information systems. ALTEN works with key actors in the Aeronautics, Space, Defence, Security & Naval, Automotive, Rail & Mobility, Energy & Environment, Life Sciences & Health, Industrial Equipment & Electronics, Telecoms, Banking, Finance & Insurance, Retail, Services & Medias, Public Services & Government sectors. The Group has a workforce of more than 54,000 employees operating in 30+ countries, 88% of whom are engineers. Its 2022 turnover was €3,78 billion. For more information, visit www.alten.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cmed and Larix fully integrated into Aixial Group, the CRO solution of ALTEN Group here
News-ID: 3073542 • Views: …
More Releases from Scott PR
Clinical trial platform provider encapsia welcomes new COO
Horsham, United Kingdom, 20th December 2022: Clinical trial management solutions provider, encapsia, has announced the appointment of Francis Destin as its new Chief Operating Officer. Francis brings more than 20 years of expertise to the role, specialising in the management of data-related projects in clinical trials and statistical analysis software. His adoption of a future-facing approach to clinical research supports encapsia's vision of transforming clinical trials for the benefit of…
Sepha's new EZ Blister+ enables 21 CFR Part 11 compliant micro-batches
Sepha, the Northern Ireland-based manufacturer of pharmaceutical packaging and equipment, has developed a new compact small-batch blister packaging machine with full traceability and electronic data storage capabilities. The EZ Blister+ meets increased demand for 21 CFR Part 11 compliant micro-batches throughout the blister production lifecycle, from R&D right through to commercial production. It will launch via a live webinar on 6th April (https://app.livestorm.co/sepha/digitalisation-of-low-volume-blister-packaging).
The EZ+ Blister answers calls from larger pharmaceutical…
Scitara Corp. raises $15m in Series B Financing to disrupt the laboratory data i …
Scitara Corp, a proven innovator in laboratory digital transformation, today announces the closing of its Series B round with an additional investment of $15m. Led by existing investor Northpond Ventures, with participation from Flybridge Capital and experienced financial advisors to the biopharma and life science tools industry, the funding will springboard Scitara’s ambitious growth plans for 2022 and beyond to solve the laboratory data integration challenge.
Scitara’s growth has been fuelled…
Global Pharmaceutical Company proves validity of AI in life sciences through Pan …
A Senior Principal Data Scientist from a leading global pharmaceutical company showcased its success stories of using Pangaea Data’s novel artificial intelligence driven product, PIES (Pangaea’s Intelligence Extractor and Summarization).
The presentation took place at the Bio-IT World Conference and Expo on 21st September 2021 and demonstrated that PIES’s inherent Natural Language Generation (NLG) methods provide clinicians and researchers with the ability to generate clinical narratives automatically based on discrete…
More Releases for Group
Specialty Insurance Market 2023 | Futuristic Technology- State Farm Group, Progr …
The Specialty Insurance market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Specialty Insurance report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The Specialty Insurance research report also provides insights of different regions that are…
Transit Packaging Market Top Key Players - STI Group, Crown Cork Group, GWP Grou …
Freight transport in transit receives a wide range of vibrational intensities over a period of time. Based on the origin, destination and network of carriers, ocean-going vessels with aircraft will vibrate with the proper amplitude. Cargo handling and sorting operations contribute to lower levels of compressive force than movement in transit. The only exception to this is when the cargo moves in transit. This allows heavier packages to slip into…
Global Baijiu Market 2019-2024 - Kweichow Moutai Group, Wuliangye, Yanghe Brewer …
Global Baijiu Market 2019-2024:
“Global Baijiu Market” report focuses on the comprehensive study of the market involving technological developments, future plans, supply, sales revenue, production, dimensions, overview, manufacturers, growth rate, price, deals, and revenue for the detailed analysis of the Baijiu Market. Moreover, report of the Baijiu efficiently offers the needed characteristics of the global Baijiu market for the individuals and people looking for the business for investments, mergers & acquisitions…
White Spirits Market 2019 Wuliangye Kweichow Moutai Group Yanghe Brewery Daohuax …
As per global White Spirits market report for the period of 2018 to 2023, the White Spirits market is likely to reach an estimate of USD xx million at the end of the 2023 rising at the rate of CAGR xx% throughout the forecast period of 2019 to 2024. The global White Spirits market report covers an exhaustive understanding of the White Spirits that encompasses various important factors like the…
Automotive Metal Market ’size 2019 by Top Key Players: ArcelorMittal, China Ba …
The ‘Automotive Metal Market’ research report assembled by Market Study Report, LLC, provides a succinct analysis on the recent market trends. In addition, the report offers a thorough abstract on the statistics, market estimates and revenue forecasts, which further highlights its position in the industry, in tandem with the growth strategies adopted by leading industry players.
This report focuses on the Automotive Metal in global market, especially in North America, Europe…
Steel Ingot Market Outlook and Forecasts 2018 to 2025 and Key Players: ArcelorMi …
The “Global Steel Ingot Analysis to 2025” is a specialized and in-depth study of the Steel Ingot industry with a focus on the global market trend. The report aims to provide an overview of global Steel Ingot with detailed market segmentation by component, type, application and geography. The global Steel Ingot market is expected to witness high growth during the forecast period. The report provides key statistics on the market…